Major updates in the biotech sector over the past four trading days were on the pipeline and regulatory front from companies like Alkermes (ALKS – Analyst Report) and Amgen (AMGN – Analyst Report) among others.Recap of the Week’s Most Important Stories1. Alkermes’ experimental schizophrenia treatment, ALKS 3831, fared well in a mid-stage study. Earlier this year, the company had said […]
In a recent report, analysts at JMP Securities discussed five biotech names that are on their radar. Here’s a breakdown of what they had to say.
BIND Therapeutics Inc (NASDAQ: BIND)
BIND will be presenting three posters on its Accurin technology at the American Association of Cancer Research (AACR) meeting in Philadelphia in April.Although the Accurin data the company will be showcasing […]
Related 13 Management Changes That Happened This Week8-K Filing Shows Bind Therapeutics Closes Offering Of StockRelated Morning Market LosersCerulean Announces Completion of Enrollment of a Phase 1b/2 Study of CRLX101 in Combination with Avastin® in Relapsed Renal Cell CarcinomaCerulean Pharma (CERU) Shares March Higher, Can It Continue? – Tale of the Tape(Zacks)In a recent report, analysts at JMP Securities discussed […]
StockRadars, a Bangkok-based service that aims to demystify investing in Asia’s stock markets, has scored a deal of its own after parent company SiamSquared closed a Series A round from Japan’s CyberAgent Ventures and East Ventures.The deal is undisclosed, but TechCrunch understands that it is around $800,000 and at a $5-10 million valuation for the Thai startup. StockRadars currently covers the public markets in Thailand […]
The biotech sector has started 2015 with the announcement of several deals. Both Kite Pharma (KITE – Snapshot Report) and Isis Pharmaceuticals (ISIS – Analyst Report) saw their share prices increasing on collaboration agreements with major companies. Meanwhile, Alkermes (ALKS – Analyst Report) has also started the year on a positive note with encouraging pipeline data.Recap of the Week’s Most […]
When it comes to traditional biotech investing — that is, biotech stocks in healthcare — it’s not uncommon for a company to fall dramatically after a negative outcome from a binary event, such as a failed clinical trial. In some instances, development-stage companies with no products on the market and few revenue streams can see their market value fall below […]
Chip giant Intel has found a way to demonstrate the value of big data analytics in the big health care industry. It’s partnering with Michael J. Fox Foundation for Parkinson’s Research and working on a study that will pull patterns from data coming from patients’ wearable devices.The collaboration, which Intel announced at an event this morning, will give Intel an opportunity […]
George Dyson. Credit: edge.orgIf you read about Big Data for very long, a quote from science historian George Dyson is sure to come up: “Big data is what happened when the cost of keeping information became less than the cost of throwing it away.”That will be a platform to talk about the challenges, etc.But there is a bigger problem that […]
Points of light (cc) by James Marvin Phelps.
Last week I attended the Points of Light National Conference on Volunteering and Service. Aptly named “Service Unites,” it gathered more than 5,000 leaders from the nonprofit, corporate and civic sectors to learn and help shape the future of volunteerism. These changemakers from across the country were examining how to put civic engagement […]
Cambridge-based predictive analytics company RapidMiner announced on Tuesday that it has acquired Radoop, an analytics company that optimizes the big data platform known as Hadoop.
Prior to today’s move, RapidMiner already had an existing partnership with the company, incorporating Radoop’s enterprise-geared big data analytics products into RapidMiner’s suite of predictive analytics offerings. With the acquisition, more of Radoop’s Hadoop tools can […]